Skip to main content

Advertisement

SpringerLink
Log in

Scaling Up of Intermittent Preventive Treatment of Malaria in Pregnancy Using Sulphadoxine–Pyrimethamine: Prospects and Challenges

  • Published:
Maternal and Child Health Journal Aims and scope Submit manuscript

Abstract

Intermittent preventive treatment of malaria during pregnancy with sulphadoxine–pyrimethamine (IPTpSP) is one of the major strategies of malaria control in most African countries where malaria is endemic. The use of sulphadoxine–pyrimethamine (SP) for intermittent preventive treatment of malaria during pregnancy was adopted when proof of its superiority to weekly prophylactic dosing with either chloroquine or pyrimethamine became evident from studies in different malaria endemic countries. The administration of 2 and 3 treatment doses of SP for HIV-negative and HIV-positive pregnant women respectively, given after quickening and at an interval not less than 4 weeks was recommended. The prospects of this control strategy lies on the efficacy of SP, convenient treatment dose and high compliance rate. However, the implementation of this strategy and the efficacy of SP are faced with challenges such as: timing of SP administration, rising levels of parasite resistance to SP in the general population, effect of folate supplementation, adequacy of the recommended doses with regards to malaria endemicity and HIV status, interactions between SP and antiretroviral drugs and low coverage in the bid to scale-up its use. This review highlights the prospects and challenges of scaling up IPTp-SP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. World Health Organization. (2004). A strategic framework for malaria prevention and control during pregnancy in the African region. WHO Regional Office for Africa, Brazzaville, Republic of Congo. AFR/MAL/04/01. Available at: http://www.who.int/malaria/rbm/Attachment/20041004/malaria_pregnancy_str_framework.pdf.

  2. Federal Ministry of Health (FMOH). (2005). National antimalarial treatment policy. Federal Ministry of Health Nigeria, National Malaria and Vector Control Division Abuja, Nigeria, 52 pp.

  3. World Health Organization. (1986). WHO expert committee on malaria. Eighteenth report. Geneva. World Health Organization, WHO technical report series.

  4. Salihu, H. M., Naik, E. G., Tchuinguem, G., Bosny, J. P., & Dagne, G. (2002). Weekly chloroquine prophylaxis and the effect on maternal haemoglobin status at delivery. Tropical Medicine and International Health, 7, 29–34.

    Article  PubMed  CAS  Google Scholar 

  5. Denoeud, L., Fievet, N., Aubouy, A., Ayemonna, P., Kiniffo, R., Massougbodji, A., et al. (2007). Is chloroquine chemoprophylaxis still effective to prevent low birth weight? Results of a study in Benin. Malaria Journal, 6, 27.

    Article  PubMed  Google Scholar 

  6. Bertin, G., Tuikue Ndam, N., Jafari-Guemouri, S., Fievet, N., Renart, E., Sow, S., et al. (2005). High prevalence of Plasmodium falciparum pfcrt K76T mutation in pregnant women taking chloroquine prophylaxis in Senegal. Journal of Antimicrobial Chemotherapy, 55, 788–791.

    Article  PubMed  CAS  Google Scholar 

  7. Diallo, M., Dabo, C. A., Saye, R., Yattara, O., Diarra, M. A., Kayentao, K., et al. (2007). Randomized clinical trial of two malaria prophylaxis regimens for pregnant women in Faladie, Mali. Médecine Tropicale, 67, 477–480.

    PubMed  CAS  Google Scholar 

  8. Kayentao, K., Mungai, M., Parise, M., Kodio, M., Keita, A. S., Coulibaly, D., et al. (2007). Assessing malaria burden during pregnancy in Mali. Acta Tropica, 102, 106–112.

    Article  PubMed  Google Scholar 

  9. Tukur, I. U., Thacher, T. D., Sagay, A. S., & Madaki, J. K. (2007). A comparison of sulfadoxine-pyrimethamine with chloroquine and pyrimethamine for prevention of malaria in pregnant Nigerian women. American Journal of Tropical Medicine and Hygiene, 76, 1019–1023.

    PubMed  CAS  Google Scholar 

  10. Schultz, L. J., Steketee, R. W., Macheso, A., Kazembe, P., Chitsulo, L., & Wirima, J. J. (1994). The efficacy of antimalarial regimens containing sulphadoxine–pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. American Journal of Tropical Medicine and Hygiene, 51, 515–522.

    PubMed  CAS  Google Scholar 

  11. Sirima, S. B., Sawadogo, R., Moran, A. C., Konate, A., Diarra, A., Yameogo, M., et al. (2003). Failure of a chloroquine chemoprophylaxis program to adequately prevent malaria during pregnancy in Koupela District, Burkina Faso. Clinical Infectious Diseases, 36, 1374–1382.

    Article  PubMed  CAS  Google Scholar 

  12. Nahlen, B. L., Alakija, T., Ogunbode, O., Adetoro, O., Akintunde, A., Nguyen-Dinh, P., et al. (1989). Lack of pyrimethamine prophylaxis in pregnant Nigerian women. Lancet, 8667, 830–834.

    Article  Google Scholar 

  13. AlKadi, H. O. (2007). Antimalarial drug toxicity: a review. Chemotherapy, 53, 385–391.

    Article  PubMed  CAS  Google Scholar 

  14. Newman, R. D., Parise, M. E., Slutsker, L., Nahlen, B., & Steketee, R. W. (2003). Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: Implications for prevention programmes in Plasmodium falciparum-endemic sub-Saharan Africa. Tropical Medicine and International Health, 8, 488–506.

    Article  PubMed  CAS  Google Scholar 

  15. Peters, P. J., Thigpen, M. C., Parise, M. E., & Newman, R. D. (2007). Safety and toxicity of sulfadoxine/pyrimethamine: Implications for malaria prevention in pregnancy using intermittent preventive treatment. Drug Safety, 30(6), 481–501.

    Article  PubMed  CAS  Google Scholar 

  16. Shulman, C. E., & Dorman, E. K. (2003). Importance and prevention of malaria in pregnancy. Transactions of the Royal Society of Tropical Medicine and Hygiene, 97, 30–35.

    Article  PubMed  Google Scholar 

  17. Greenwood, B. (2004). The use of antimalarial drugs to prevent malaria in the population of malaria-endemic areas. American Journal of Tropical Medicine and Hygiene, 70, 1–7.

    PubMed  CAS  Google Scholar 

  18. Federal Ministry of Health (FMOH). (2005). National guidelines and strategies for malaria prevention and control during pregnancy. Federal Ministry of Health, Nigeria, 50 pp.

  19. Nyunt, M. M., Adam, I., Kayentao, K., van Dijk, J., Thuma, P., Mauff, K., et al. (2009). Pharmacokinetics of sulfadoxine and pyrimethamine in intermittent preventive treatment of malaria in pregnancy. Clin Pharmacol Ther. doi:10.1038/clpt.2009.177.

  20. Nosten, F., McGready, R., & Mutabingwa, T. (2007). Case management of malaria in pregnancy. The Lancet Infectious Diseases, 7, 118–125.

    Article  PubMed  Google Scholar 

  21. IPCA. (2006). Sulfadoxine–pyrimethamine—Laridox. Accessed January 3, 2007, from www.malaria-ipca.com.

  22. Weidekamm, E., Plozza-Nottebrock, H., Forgo, I., & Dubach, U. C. (1982). Plasma concentrations in pyrimethamine and sulfadoxine and evaluation of pharmacokinetic data by computerized curve fitting. Bulletin of the World Health Organization, 60, 115–122.

    PubMed  CAS  Google Scholar 

  23. Bzik, D. J., Li, W. B., Horii, T., & Inselburg, J. (1987). Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene. Proceedings of the National Academy of Sciences of the United States of America, 84, 8360–8364.

    Article  PubMed  CAS  Google Scholar 

  24. Sibley, C. H., Hyde, J. E., Sims, P. F., Plowe, C. V., Kublin, J. G., Mberu, E. K., et al. (2001). Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: What next? Trends in Parasitology, 17, 582–588.

    Article  PubMed  CAS  Google Scholar 

  25. World Health Organization. (2006). WHO guidelines for the treatment of malaria. Geneva: World Health Organization. WHO/HTM/MAL 2006.1108.

  26. Marchesini, P., & Crawley, J. (2004). Reducing the burden of malaria in pregnancy. Roll Back Malaria, Mera I–IV.

  27. Olliaro, P. L., Delenne, H., Cisse, M., Badiane, M., Olliaro, A., Vaillant, M., et al. (2008). Implementation of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine (IPTp-SP) at a district health centre in rural Senegal. Malaria Journal, 7, 234.

    Article  PubMed  Google Scholar 

  28. Mbonye, A. K., Bygbjerg, I. C., & Magnussen, P. (2007). A community-based delivery system of intermittent preventive treatment of malaria in pregnancy and its effect on use of essential maternity care at health units in Uganda. Transactions of the Royal Society of Tropical Medicine and Hygiene, 101, 1088–1095.

    Article  PubMed  Google Scholar 

  29. ter Kuile, F., van Eijk, A., & Filler, S. (2007). Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy. JAMA, 297, 2603–2616.

    Article  PubMed  CAS  Google Scholar 

  30. Falade, C., Yusuf, B. O., Fadero, F. F., Mokuolu, O. A., Hamer, D. H., & Salako, L. A. (2007). Intermittent preventive treatment with sulfadoxine-pyrimethamine is effective in preventing maternal and placental malaria in Ibadan, south-western Nigeria. Malaria Journal, 6, 88.

    Article  PubMed  Google Scholar 

  31. Hommerich, L., von Oertzen, C., Bedu-Addo, G., Holmberg, V., Acquah, P. A., Eggelte, T. A., et al. (2007). Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy. Malaria Journal, 6, 144.

    Article  PubMed  Google Scholar 

  32. Challis, K., Osman, N. B., Cotiro, M., Nordahl, G., Dgedge, M., & Bergstrom, S. (2004). Impact of double dose sulfadoxine-pyrimethamine to reduce prevalence of pregnancy malaria in southern Mozambique. Tropical Medicine and International Health, 9, 1066–1073.

    Article  PubMed  CAS  Google Scholar 

  33. van Eijk, A. M., Ayisi, J. G., ter Kuile, F. O., Otieno, J. A., Misore, A. O., Odondi, J. O., et al. (2004). Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine for control of malaria in pregnancy in western Kenya: A hospital-based based study. Tropical Medicine and International Health, 9, 351–360.

    Article  PubMed  Google Scholar 

  34. Parise, E. M., Ayisi, G. J., Nahlen, L. B., Schultz, J. L., Roberts, M. J., Misore, A., et al. (1998). Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. American Journal of Tropical Medicine and Hygiene, 59, 813–822.

    PubMed  CAS  Google Scholar 

  35. Rogerson, S., Chaluluka, E., Kanjala, M., Mkundika, P., Mhango, C., & Molyneux, M. (2000). Intermittent sulfadoxine-pyrimethamine in pregnancy effectiveness against malaria morbidity in Blantyre, Malawi, in 1997–99. Transactions of the Royal Society of Tropical Medicine and Hygiene, 94, 549–553.

    Article  PubMed  CAS  Google Scholar 

  36. Ramharter, M., Schuster, K., Bouyou-Akotet, M. K., Adegnika, A. A., Schmits, K., Mombo-Ngoma, G., et al. (2007). Malaria in pregnancy before and after the implementation of a national IPTp program in Gabon. American Journal of Tropical Medicine and Hygiene, 77, 418–422.

    PubMed  Google Scholar 

  37. Hastings, I. M., Watkins, W. M., & White, N. J. (2002). The evolution of drug-resistant malaria: the role of drug elimination half-life. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 357, 505–519.

    Article  PubMed  CAS  Google Scholar 

  38. Prudhomme O’Meara, W., Smith, D. L., & McKenzie, F. E. (2006). Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria. PLoS Medicine, 3, e141.

    Article  Google Scholar 

  39. World Health Organization. (2005). Recommendations on the use of sulfadoxine-pyrimethamine (SP) for intermittent preventive treatment during pregnancy (IPT) in areas of moderate to high resistance to SP in the African Region October 2005 World Health Organization. Regional Office for Africa.

  40. Dzinjalamala, F. K., Macheso, A. M., Kublin, J. G., Taylor, T. E., Barnes, K. I., Molyneux, M. E., et al. (2005). Association between the pharmacokinetics and in vivo therapeutic efficacy of sulfadoxine-pyrimethamine in Malawian children. Antimicrobial Agents and Chemotherapy, 49, 3601–3606.

    Article  PubMed  CAS  Google Scholar 

  41. Massaga, J. J., Kitua, A. Y., Lemnge, M. M., Akida, J. A., Malle, L. N., Ronn, A. M., et al. (2003). Effect of intermittent treatment with amodiaquine on anaemia and malarial fevers in infants in Tanzania: A randomised placebo-controlled trial. Lancet, 361, 1853–1860.

    Article  PubMed  CAS  Google Scholar 

  42. Watkins, W. M., & Mosobo, M. (1993). Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: Selective pressure for resistance is a function of long elimination half-life. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87(1), 75–78.

    Article  PubMed  CAS  Google Scholar 

  43. Hyde, J. E. (1990). The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites. Pharmacology and Therapeutics, 48, 45–59.

    Article  PubMed  Google Scholar 

  44. Wang, P., Read, M., Sims, P. F., & Hyde, J. E. (1997). Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization. Molecular Microbiology, 23, 979–986.

    Article  PubMed  CAS  Google Scholar 

  45. Kublin, J. G., Dzinjalamala, F. K., Kamwendo, D. D., Malkin, E. M., Cortese, J. F., Martino, L. M., et al. (2002). Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. Journal of Infectious Diseases, 185, 380–388.

    Article  PubMed  CAS  Google Scholar 

  46. Schönfeld, M., Miranda, I. B., Schunk, M., Maduhu, I., Maboko, L., Hoelscher, M., et al. (2007). Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania. Malaria Journal, 6, 2.

    Article  PubMed  Google Scholar 

  47. Happi, C. T., Gbotosho, G. O., Folarin, O. A., Akinboye, D. O., Yusuf, B. O., Ebong, O. O., et al. (2005). Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria. Acta Tropica, 95, 183–193.

    Article  PubMed  CAS  Google Scholar 

  48. Tamaru, T., & Picciano, M. F. (2006). Folate and human reproduction. American Journal of Clinical Nutrition, 83, 993–1016.

    Google Scholar 

  49. Stolzfus, R. J., & Dreyfuss, M. L. (1997). Guidelines for the use of iron supplements to prevent and treat iron deficiency anemia. International Nutritional Anemia Consultative Group (39 pp). Washington, DC: ILSI Press.

  50. Ouma, P., Parise, M. E., Hamel, M. J., ter Kuile, F. O., Otieno, K., Ayisi, J. G., et al. (2006). A randomized controlled trial of folate supplementation when treating malaria in pregnancy with sulfadoxine-pyrimethamine. PLoS Clinical Trials, 1, e28.

    Article  PubMed  Google Scholar 

  51. Krungkrai, J., Webster, H. K., & Yuthavong, Y. (1989). De novo and salvage biosynthesis of pteroylpentaglutamates in the human malaria parasite, Plasmodium falciparum. Molecular and Biochemical Parasitology, 32, 25–37.

    Article  PubMed  CAS  Google Scholar 

  52. Wang, P., Wang, Q., Aspinall, T. V., Sims, P. F., & Hyde, J. E. (2004). Transfection studies to explore essential folate metabolism and antifolate drug synergy in the human malaria parasite Plasmodium falciparum. Molecular Microbiology, 51, 1425–1438.

    Article  PubMed  CAS  Google Scholar 

  53. Metz, J. (2007). Folic acid metabolism and malaria. Food and Nutrition Bulletin, 28, S540–S549.

    PubMed  Google Scholar 

  54. Nduati, E., Diriye, A., Ommeh, S., Mwai, L., Kiara, S., Masseno, V., et al. (2008). Effect of folate derivatives on the activity of antifolate drugs used against malaria and cancer. Parasitology Research, 102, 1227–1234.

    Article  PubMed  Google Scholar 

  55. Federal Ministry of Health. (2007). Malaria review. Federal Ministry of Health Nigeria.

  56. Hill, J., & Kazembe, P. (2006). Reaching the Abuja target for intermittent preventive treatment of malaria in pregnancy in African women: A review of progress and operational challenges. Tropical Medicine and International Health, 11, 409–418.

    Article  PubMed  Google Scholar 

  57. Briand, V., Cottrell, G., Massougbodji, A., & Cot, M. (2007). Intermittent preventive treatment for the prevention of malaria during pregnancy in high transmission areas. Malaria Journal, 6, 160.

    Article  PubMed  Google Scholar 

  58. Ouma, P. O., Van Eijk, A. M., Hamel, M. J., Sikuku, E., Odhiambo, F., Munguti, K., et al. (2007). The effect of health care worker training on the use of intermittent preventive treatment for malaria in pregnancy in rural western Kenya. Tropical Medicine and International Health, 12(8), 953–961.

    Article  PubMed  CAS  Google Scholar 

  59. Akinleye, S. O., Falade, C. O., & Ajayi, I. O. (2009). Knowledge and utilization of intermittent preventive treatment for malaria among pregnant women attending antenatal clinics in primary health care centers in rural southwest, Nigeria: A cross-sectional study. BMC Pregnancy and Childbirth, 9, 28.

    Article  PubMed  Google Scholar 

  60. Filler, S. J., Kazembe, P., Thigpen, M., Macheso, A., Parise, M. E., Newman, R. D., et al. (2006). Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi. Journal of Infectious Diseases, 194, 286–293.

    Article  PubMed  CAS  Google Scholar 

  61. Hamer, D. H., Mwanakasale, V., MacLeod, W. B., Chalwe, V., Mukwamataba, D., Champo, D., et al. (2007). Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women. Journal of Infectious Diseases, 196, 1585–1594.

    Article  PubMed  CAS  Google Scholar 

  62. Gill, C. J., MacLeod, W. B., Mwanakasale, V., Chalwe, V., Mwananyanda, L., Champo, D., et al. (2007). Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women. Journal of Infectious Diseases, 196, 1577–1584.

    Article  PubMed  CAS  Google Scholar 

  63. McGready, R., Davison, B., Stepniewska, K., Cho, T., Shee, H., Brockman, A., et al. (2004). The effects of Plasmodium falciparum and P. vivax infections on placental histopathology in an area of low malaria transmission. American Journal of Tropical Medicine and Hygiene, 70, 398–407.

    PubMed  Google Scholar 

  64. Gamble, C., Ekwaru, J., & ter Kuile, F. (2006). Insecticide-treated nets for preventing malaria in pregnancy. Cochrane Database Syst Rev, CD003755.

  65. White, N. J. (2005). Intermittent presumptive treatment for malaria. PLoS Medicine, 2, 28–33.

    Article  Google Scholar 

  66. Sirima, S. B., Cotte, A. H., Konate, A., Moran, A. C., Asamoa, K., Bougouma, E. C., et al. (2006). Malaria prevention during pregnancy: Assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso. American Journal of Tropical Medicine and Hygiene, 75, 205–211.

    PubMed  Google Scholar 

  67. van Eijk, A. M., Ayisi, J. G., ter Kuile, F. O., Slutsker, L., Otieno, J. A., Misore, A. O., et al. (2004). Implementation of intermittent preventive treatment with sulfadoxine-pyrimethamine for control of malaria in pregnancy in Kisumu, western Kenya. Tropical Medicine and International Health, 9, 630–637.

    Article  PubMed  Google Scholar 

  68. Taylor, W., & White, N. (2004). Antimalarial drug toxicity: A review. Drug Safety, 27, 25–61.

    Article  PubMed  CAS  Google Scholar 

  69. Andersen, D., Blanc, W., Crozier, D., & Silverman, W. (1956). A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics, 18, 614–625.

    PubMed  CAS  Google Scholar 

  70. Forna, F., McConnell, M., & Kitabire, F. N. (2006). Systematic review of the safety of trimethoprim-sulfamethoxazole for prophylaxis in HIV-infected pregnant women: Implications for resource-limited settings. AIDS Reviews, 8, 24–36.

    PubMed  Google Scholar 

  71. Brentlinger, P. E., Behrens, C. B., & Micek, M. A. (2006). Challenges in the concurrent management of malaria and HIV in pregnancy in sub-Saharan Africa. The Lancet Infectious Diseases, 6, 100–111.

    Article  PubMed  Google Scholar 

  72. Gimnig, J. E., MacArthur, J. R., M’bang’ombe, M., Kramer, M. H., Chizani, N., Stern, R. S., et al. (2006). Severe cutaneous reactions to sulfadoxine-pyrimethamine and trimethoprim-sulfamethoxazole in Blantyre District, Malawi. American Journal of Tropical Medicine and Hygiene, 74, 738–743.

    PubMed  CAS  Google Scholar 

  73. Moore, R., Fortgang, I., Keruly, J., & Chaisson, R. (1996). Adverse events from drug therapy for human immunodeficiency virus disease. American Journal of Medicine, 101, 34–40.

    Article  PubMed  CAS  Google Scholar 

  74. Allen, J., Carr, A., Chaisson, R., Freedberg, K., McKay, J., & Polis, M. (1992). Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with HIV. JAMA, 267, 2294–2299.

    Article  Google Scholar 

  75. Iyer, J. K., Milhous, W. K., Cortese, J. F., Kublin, J. G., & Plowe, C. V. (2001). Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine. Lancet, 358, 1066–1067.

    Article  PubMed  CAS  Google Scholar 

  76. Duraisingh, M. T., Curtis, J., & Warhurst, D. C. (1998). Plasmodium falciparum: Detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. Experimental Parasitology, 89, 1–8.

    Article  PubMed  CAS  Google Scholar 

  77. Jelinek, T., Kilian, A. H., Curtis, J., Duraisingh, M. T., Kabagambe, G., von Sonnenburg, F., et al. (1999). Plasmodium falciparum: Selection of serine 108 of dihydrofolate reductase during treatment of uncomplicated malaria with co-trimoxazole in Ugandan children. American Journal of Tropical Medicine and Hygiene, 61, 125–130.

    PubMed  CAS  Google Scholar 

  78. Hamel, M. J., Greene, C., Chiller, T., Ouma, P., Polyak, C., Otieno, K., et al. (2008). Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults? American Journal of Tropical Medicine and Hygiene, 79, 320–330.

    PubMed  Google Scholar 

  79. Mount, A. M., Mwapasa, V., Elliott, S. R., Beeson, J. G., Tadesse, E., Lema, V. M., et al. (2004). Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection. Lancet, 363, 1860–1867.

    Article  PubMed  Google Scholar 

  80. Steketee, R., Wirima, J., Hightower, A., Slutsker, L., Heymann, D., & Breman, J. (1996). The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi. American Journal of Tropical Medicine and Hygiene, 55, 33–41.

    PubMed  CAS  Google Scholar 

  81. Vanhauwere, B., Maradit, H., & Kerr, L. (1998). Post-marketing surveillance of prophylactic mefloquine (Lariam) use in pregnancy. American Journal of Tropical Medicine and Hygiene, 58, 17–21.

    PubMed  CAS  Google Scholar 

  82. World Health Organization. (1993). Prevention and management of severe anaemia in pregnancy. Geneva: World Health Organization. WHO/FHE/MSM/93.5.

  83. National Institutes of Health USA. (2006). Intermittent preventive treatment during pregnancy in Benin: A randomized, open, and equivalent trial comparing sulfadoxine–pyrimethamine with mefloquine. National Institutes of Health USA. http://www.clinicaltrials.gov/ct/show/NCT00274235.

  84. Clark, R. L. (2009). Embryotoxicity of the artemisinin antimalarials and potential consequences for use in women in the first trimester. Reproductive Toxicology, 28, 285–296.

    Article  PubMed  CAS  Google Scholar 

  85. Kalilani, L., Mofolo, I., Chaponda, M., Rogerson, S. J., Alker, A. P., Kwiek, J. J., et al. (2007). a randomized controlled pilot trial of azithromycin or artesunate added to sulfadoxine-pyrimethamine as treatment for malaria in pregnant Women. PLoS One, 2, e1166.

    Article  PubMed  Google Scholar 

  86. Andersen, S. L., Oloo, A. J., Gordon, D. M., Ragama, O. B., Aleman, G. M., Berman, J. D., et al. (1998). Successful double-blinded, randomized, placebo-controlled field trial of azithromycin and doxycycline as prophylaxis for malaria in western Kenya. Clinical Infectious Diseases, 26(1), 146–150.

    Article  PubMed  CAS  Google Scholar 

  87. Gray, R. H., Wabwire-Mangen, F., Kigozi, G., Sewankambo, N. K., Serwadda, D., Moulton, L. H., et al. (2001). Randomized trial of presumptive sexually transmitted disease therapy during pregnancy in Rakai, Uganda. American Journal of Obstetrics and Gynecology, 185(5), 1209–1217.

    Article  PubMed  CAS  Google Scholar 

  88. Sarkar, M., Woodland, C. C., Koren, G., & Einarson, A. R. (2006). Pregnancy outcome following gestational exposure to azithromycin. BMC Pregnancy and Childbirth, 6, 18.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Microbiology, University of Lagos, Ishaga Road, Ojuwelegba, Lagos, Suru-Lere, LA, Nigeria

    Wellington Aghoghovwia Oyibo & Chimere Obiora Agomo

Authors
  1. Wellington Aghoghovwia Oyibo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chimere Obiora Agomo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wellington Aghoghovwia Oyibo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oyibo, W.A., Agomo, C.O. Scaling Up of Intermittent Preventive Treatment of Malaria in Pregnancy Using Sulphadoxine–Pyrimethamine: Prospects and Challenges. Matern Child Health J 15, 542–552 (2011). https://doi.org/10.1007/s10995-010-0608-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10995-010-0608-5

Keywords

Search

Navigation